Pharmacist-Led Diabetes Control Intervention and Health Outcomes in Hispanic Patients With Diabetes
Authors' conclusion
In this quality improvement study of UCMyRx among Hispanic patients with T2D, a negative association was observed between UCMyRx exposure and HbA1c concentration but not SBP. Pharmacist-led intervention may be a strategy for improving outcomes among Hispanic patients with T2D.
Study context
- Population
- Hispanic adults (≥18 years) with T2D at University of California, Los Angeles primary care clinics, with hemoglobin A1c (HbA1c) ≥8% and/or systolic blood pressure (SBP) ≥140 mm Hg; study window March 2, 2013-December 31, 2018analyzed · with HbA1c ≥8% 396 · /or SBP ≥140 mm Hg 795
- Participants
- 931 adults
- Comparison
- Pharmacist-led intervention vs usual care
- Outcome
- Pre- to post-index date changes in HbA1c and SBP
Methodological detailsdifference-in-differences design, electronic health record data
- Difference-in-differences design
- Electronic health record data
Main finding
As reported in the abstract
Β (HbA1c)
−0.46 %
95% CI −0.84% to −0.07%
reduction in HbA1c
Β (SBP)
−1.71 mm Hg
95% CI −4.00 to 0.58
no change in SBP
Original publication
Pharmacist-Led Diabetes Control Intervention and Health Outcomes in Hispanic Patients With Diabetes. JAMA Netw Open. Published 5 September 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →